| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.AUTREV.2006.12.006 |
| P698 | PubMed publication ID | 17854742 |
| P50 | author | Marco Matucci-Cerinic | Q19859583 |
| Roberto Giacomelli | Q42416418 | ||
| Serena Guiducci | Q47265812 | ||
| P2093 | author name string | Serena Guiducci | |
| P433 | issue | 8 | |
| P304 | page(s) | 520-523 | |
| P577 | publication date | 2007-01-12 | |
| P1433 | published in | Autoimmunity Reviews | Q15754966 |
| P1476 | title | Vascular complications of scleroderma | |
| P478 | volume | 6 |
| Q38019848 | 'Go with the flow ': a review of methods and advancements in blood flow imaging. |
| Q39955870 | A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis |
| Q37886415 | A review on thromboangiitis obliterans pathophysiology: thrombosis and angiitis, which is to blame? |
| Q38840236 | Adipose-Derived Mesenchymal Stem Cells in Autoimmune Disorders: State of the Art and Perspectives for Systemic Sclerosis. |
| Q41169103 | Angiogenesis Dysregulation in the Pathogenesis of Systemic Sclerosis. |
| Q39947827 | Associations with digital ulcers in a large cohort of systemic sclerosis: Results from the Canadian Scleroderma Research Group registry |
| Q37319989 | Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings |
| Q37616438 | Biomechanical podiatric evaluation in an Italian cohort of patients with systemic sclerosis: A pilot study |
| Q46413425 | Bosentan fosters microvascular de-remodelling in systemic sclerosis |
| Q34495257 | Cardiovascular disease in rheumatoid arthritis: a systematic literature review in latin america |
| Q34081242 | Cardiovascular involvement in autoimmune diseases |
| Q33373590 | Comparison of thermal infrared and laser doppler imaging in the assessment of cutaneous tissue perfusion in scleroderma patients and healthy controls |
| Q39938714 | Digital gangrene associated with anticentromere antibodies: a case report |
| Q39929129 | Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions |
| Q47591657 | Efficacy and Safety of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis: A Randomized, Placebo-Controlled, Phase II Study |
| Q37596505 | Endothelial cells recruit macrophages and contribute to a fibrotic milieu in bleomycin lung injury |
| Q37624581 | Endothelial progenitor cells: novel players in the pathogenesis of rheumatic diseases |
| Q34613928 | Enhanced angiogenic potency of monocytic endothelial progenitor cells in patients with systemic sclerosis |
| Q38206104 | Fibrosis--a lethal component of systemic sclerosis |
| Q52845511 | Foot health needs in people with systemic sclerosis: an audit of foot health care provision. |
| Q39084290 | Geographic variation as a risk factor for digital ulcers in systemic sclerosis patients: a multicentre registry |
| Q40446240 | Hyperbaric oxygen therapy for chronic ulcers in systemic sclerosis - case series |
| Q40170361 | Increased intrarenal arterial stiffness may predict the occurrence of new digital ulcers in systemic sclerosis |
| Q46260271 | Increased plasma levels of the VEGF165b splice variant are associated with the severity of nailfold capillary loss in systemic sclerosis |
| Q38304255 | Intravenous immunoglobulins (IVIG) in systemic sclerosis: a challenging yet promising future |
| Q28551230 | Intrinsic Deregulation of Vascular Smooth Muscle and Myofibroblast Differentiation in Mesenchymal Stromal Cells from Patients with Systemic Sclerosis |
| Q37356850 | Lack of evidence for bacterial infections in skin in patients with systemic sclerosis |
| Q45933133 | Long-term beneficial effects of statins on vascular manifestations in patients with systemic sclerosis. |
| Q37310583 | Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis |
| Q37265800 | Mechanisms of vascular damage in SSc--implications for vascular treatment strategies |
| Q37622943 | Mechanisms of vascular damage in systemic sclerosis |
| Q44797000 | Nailfold capillaroscopy in systemic sclerosis: is there any difference between videocapillaroscopy and dermatoscopy? |
| Q51347200 | Oxygen absorption by skin exposed to oxygen supersaturated water. |
| Q37282939 | Pericytes: A newly recognized player in wound healing |
| Q90639907 | Prominence of IL6, IGF, TLR, and Bioenergetics Pathway Perturbation in Lung Tissues of Scleroderma Patients With Pulmonary Fibrosis |
| Q37365318 | Recent advances in the treatment of systemic sclerosis |
| Q33965825 | Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with connective tissue diseases |
| Q35313168 | Scleroderma and evidence based non-pharmaceutical treatment modalities for digital ulcers: a systematic review |
| Q58040981 | Semaphorin 3A: an immunoregulator in systemic sclerosis |
| Q54977617 | Sex differences in pulmonary arterial hypertension: role of infection and autoimmunity in the pathogenesis of disease. |
| Q46600330 | Simvastatin prevents vascular complications in the chronic reactive oxygen species murine model of systemic sclerosis |
| Q42369819 | Sphingosine-1-Phosphate Receptor 5 Modulates Early-Stage Processes during Fibrogenesis in a Mouse Model of Systemic Sclerosis: A Pilot Study |
| Q39897395 | The treatment with N-acetylcysteine of Raynaud's phenomenon and ischemic ulcers therapy in sclerodermic patients: a prospective observational study of 50 patients. |
| Q42492897 | Tissue factor-thrombin signaling enhances the fibrotic activity of myofibroblasts in systemic sclerosis through up-regulation of endothelin receptor A. |
| Q58758876 | Vascular Leaking, a Pivotal and Early Pathogenetic Event in Systemic Sclerosis: Should the Door Be Closed? |
| Q37344793 | Vascular disease in scleroderma |
Search more.